[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"inappropriate-use\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:inappropriate-use":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":5},"100582059","rak-pride-optimizing-proton-pump-inhibitor-use-through-education-and-intervention-100582059",false,"NCT06858384","RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention","From Awareness to Action: Transforming Proton Pump Inhibitor Use in Ras Al Khaimah Through Education and Intervention: the RAK -PRIDE Study","Inclusion Criteria:\n\nPhysicians will be eligible to participate if:\n\n* They are prescribing PPIs in outpatient department of the study sites\n* They have patients with potentially inappropriate PPI prescriptions\n\nPatients will be eligible to participate if:\n\n* They are ≥18 years\n* They are presenting to out-patient departments of the study sites\n* They have prescriptions of potentially inappropriate PPIs\n* Their treating physicians are included in the study\n\nExclusion Criteria:\n\nPhysicians will be excluded if:\n\n• They are involved in any other prescribing trial\n\nPatients will be excluded if:\n\n* They are unable to give informed consent, as judged by their physicians\n* They have definitive indications for PPI use","ALL","18 Years",{"count":19,"type":20},479,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this study is to determine if a pharmacist-led educational intervention can reduce the inappropriate use of proton pump inhibitors (PPIs) among adult patients (≥18 years) with potentially inappropriate PPI prescriptions in Ras Al Khaimah.\n\nThe main questions it aims to answer are:\n\n* Can a pharmacist-led education program reduce unnecessary PPI use?\n* Does the intervention improve patients' quality of life and reduce healthcare costs? Researchers will compare the intervention group (receiving pharmacist-led education and materials) to the usual care group to see if the intervention reduces PPI use and improves patient outcomes.\n\nParticipants will:\n\n* Receive educational materials from pharmacists, including a patient educational brochure, PPI patient decision aid, PPI deprescribing pamphlet, and PPI patient action plan.\n* Physicians involved will also receive a pharmaceutical intervention, which includes a physician educational brochure, PPI evidence-based deprescribing guideline, PPI deprescribing algorithm, and whiteboard videos on PPI deprescribing.\n* Patients will be followed up for 6 months to monitor changes in PPI use, symptoms, and quality of life.",[26,27,28],"Proton Pump Inhibitors","Deprescribing","Inappropriate Use",[30,31,27,32,33,34],"proton pump inhibitors","peptic ulcer disease","pharmacist-led educational intervention","inappropriate use","RAK - PRIDE","RECRUITING","2025-03-08",{"date":38,"type":39},"2025-03-12","ACTUAL",{"date":41,"type":20},"2025-03",{"date":43,"type":20},"2026-02",{"name":45,"class":46},"RAK Medical and Health Sciences University","OTHER"]